Frederick G. Vogt, Interim CEO & General Counsel at IOVANCE BIOTHERAPEUTICS, INC. (IOVA), bought 1,000 shares at $6.44 ($6K) on 2022-06-01, disclosed to the SEC on 2022-06-02.
Open-market purchase of $6k IOVA by Interim CEO & General Counsel. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |